Clik here to view.
Bristol-Myers Squibb and Pfizer Present Large Real-World Observational...
Friday, March 17th 2017 at 3:15pm UTC In this U.S. Medicare database analysis, Eliquis® (apixaban) was associated with significantly lower risk of stroke or systemic embolism and lower rate of major...
View ArticleClik here to view.
BioTime to Present at Oppenheimer 27th Annual Healthcare Conference
Monday, March 20th 2017 at 11:00am UTC ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing...
View ArticleClik here to view.
Chi-Med To Host R&D Briefings on March 29 & 30, 2017
Tuesday, March 21st 2017 at 11:06am UTC LONDON–(BUSINESS WIRE)– Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that it will host Research & Development (“R&D”)...
View ArticleClik here to view.
Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration...
Monday, March 20th 2017 at 10:59am UTC Builds upon initial 2014 alliance in oncology Includes up to eight additional targets in oncology and other therapeutic areas CytomX to receive $200 million...
View ArticleClik here to view.
Syntimmune Announces Breakthrough Results of FcRn Inhibition Published in PNAS
Monday, March 20th 2017 at 7:01pm UTC Preclinical In Vivo Models Demonstrate Blockade of FcRn-Albumin Interactions May Have Application in Protecting the Liver from Hepatotoxins SYNT002 Program to...
View ArticleClik here to view.
Thermo Fisher Scientific Showcases Newest Bioprocessing Technologies at...
Monday, March 20th 2017 at 12:00pm UTC Integrated products, software and services designed to increase customer innovation and productivity NEW YORK–(BUSINESS WIRE)– INTERPHEX 2017 – Thermo Fisher...
View ArticleClik here to view.
22nd Century Group Issues Annual Letter to Shareholders
Tuesday, March 21st 2017 at 1:50pm UTC Company believes major licensing contract or strategic partnership could generate hundreds of millions of dollars in annual revenue CLARENCE, N.Y.–(BUSINESS...
View ArticleClik here to view.
Eleven Biotherapeutics to Present at Oppenheimer’s 27th Annual Healthcare...
Monday, March 20th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing a broad pipeline of novel product...
View ArticleClik here to view.
ABMC Reports Fourth Quarter and Year End 2016 Results
Friday, March 31st 2017 at 1:30pm UTC KINDERHOOK, N.Y.–(BUSINESS WIRE)– American Bio Medica Corporation (OTCPK:ABMC) today announced financial results for the fourth quarter and year ended December...
View ArticleClik here to view.
IBRANCE® (palbociclib) Receives FDA Regular Approval and Expanded Indication...
Friday, March 31st 2017 at 6:04pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application...
View ArticleClik here to view.
Teva obtient une issue positive pour l’étiquetage de COPAXONE® 40 mg/ml 3...
Monday, April 3rd 2017 at 11:08am UTC Les docteurs disposent dorénavant d’une autre option de traitement – en cas de besoin – pour discuter avec les femmes atteintes de formes cycliques de SEP qui...
View ArticleClik here to view.
22nd Century’s “Non- or Minimally-Addictive” Cigarettes Gaining Support of...
Thursday, March 30th 2017 at 1:50pm UTC Many Scientists at the 23rd Annual Meeting of the Society for Research on Nicotine & Tobacco Support Aggressive Nicotine Reduction Policies CLARENCE,...
View ArticleClik here to view.
Kadmon Announces Amendment to Credit Agreement and Related Warrants
Monday, April 3rd 2017 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN) (“Kadmon” or the “Company”) today announced that the Company, together with its lending syndicate, led...
View ArticleClik here to view.
Verastem to Present at the 16th Annual Needham Healthcare Conference
Monday, April 3rd 2017 at 11:00am UTC BOSTON–(BUSINESS WIRE)– Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the company will present...
View ArticleClik here to view.
IRX Therapeutics to Present at the BioCentury 24th Annual Future Leaders in...
Monday, April 3rd 2017 at 3:00pm UTC NEW YORK–(BUSINESS WIRE)– IRX Therapeutics, Inc. (IRX) today announced that Mark Leuchtenberger, the Company’s President and Chief Executive Officer, will present...
View ArticleClik here to view.
Bristol-Myers Squibb and Incyte to Advance the Combination of Opdivo...
Sunday, April 2nd 2017 at 10:59am UTC Companies to initiate Phase 3 registrational trials in first-line non-small cell lung cancer across the spectrum of PD-L1 expression and first-line head and neck...
View ArticleClik here to view.
SFW Capital Partners Completes Sale of Essen BioScience to Sartorius Group AG...
Monday, April 3rd 2017 at 7:20am UTC Essen achieves substantial growth in revenues and profitability, and significant strategic, organizational, and operational transformation under SFW ownership RYE,...
View ArticleClik here to view.
The Medicines Company to Present at Needham Healthcare Conference
Thursday, March 30th 2017 at 8:30pm UTC PARSIPPANY, N.J.–(BUSINESS WIRE)– The Medicines Company (NASDAQ:MDCO) today announced that it will present at the 16th Annual Needham Healthcare Conference on...
View ArticleClik here to view.
Karyopharm and Medidata Expand Clinical Trial Partnership
Tuesday, April 4th 2017 at 12:30pm UTC Oncology-Focused Pharmaceutical Company Taps into Medidata’s Machine-Learning Technology to Pursue Better Clinical Trials for Cancer Therapies NEW YORK–(BUSINESS...
View ArticleClik here to view.
Teva to Report First Quarter 2017 Financial Results on May 11, 2017
Thursday, April 6th 2017 at 12:30pm UTC JERUSALEM–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its first quarter 2017 financial results on...
View Article